Zydus Cadila will supply 1 crore doses of its vaccine ZyCoV-D, the world's first plasmid DNA vaccine to the government of India at Rs 265 p...

On Sunday, news wire PTI reported, citing government sources, that the company had agreed to bring down the price of ZyCov-D to ₹265 a dose...

The indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received emergency use authorisation from the drug ...

A panel of experts set up by the Indian government is looking into a Delta coronavirus subvariant that has been detected in the UK

"It is anticipated that approval will soon be granted for vaccinating children with specified co-morbidities and immediately post-approval ...

The indigenous vaccine, if cleared, will be administered to children between the age-group of 2-18 and will provide a major boost to the co...

The government had on Thursday said that the indigenously-developed, world's first DNA-based needle-free COVID-19 vaccine by Zydus Cadila w...

The government is planning to get children with comorbidities the vaccine by October or November. Children between the ages of 12 and 17, w...

The drug regulator had last week approved ZyCov-D, the world’s first DNA-based vaccine against the novel coronavirus, for emergency use in ...

The three-dose ZyCov-D is the world’s first DNA-based vaccine approved for use against the disease. It’s also the first in India that can b...

Now India must leverage this capacity for its growth and for the greater good. The vaccination rate in poor countries is barely at 2%. Ramp...

The company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the d...

India’s drug regulatory authority is likely to take up Zydus Cadila's application seeking Emergency Use Authorisation (EUA) for its Covid-1...

Zydus had applied for emergency use authorisation (EUA) for its vaccine on July 1, but it is yet to be taken up by the subject expert commi...

The drug regulator will consider emergency use approval for Covid vaccines developed by Zydus Cadila for children above 12 this week. The r...

Just the two shots have been used in what India calls the world's biggest immunisation programme to cover 300 million people by August, sta...

Cadila's vaccine candidate, known as ZyCov-D, is one of dozens being developed around the world to fight the coronavirus pandemic.